Monteverde & Associates Continue Investigating Multiple Mergers for Shareholder Benefits
On June 1, 2025, Monteverde & Associates PC, recognized as one of the leading class action firms in the country, announced it is investigating a series of mergers involving several notable companies including Southern States Bancshares, LENSAR, iCAD, and BioSig Technologies. The firm, headquartered in the iconic Empire State Building in New York City, has built a strong reputation for recovering millions for shareholders, making it a key player in the legal arena dealing with mergers and acquisitions.
Starting with Southern States Bancshares, Inc. (NASDAQ: SSBK), the firm has raised concerns regarding the terms of their proposed merger with FB Financial Corporation. According to the agreement, shareholders of Southern States will receive 0.800 shares of FB Financial's common stock for every share they hold. Investors are advised to act quickly, as a shareholder vote is scheduled for June 26, 2025. Monteverde & Associates emphasizes that potential impacts on shareholder value are critically assessed to protect the interests of investors.
In a similar vein, LENSAR, Inc. (NASDAQ: LNSR) is also under review for its merger with Alcon. Under the proposed terms, LENSAR shareholders will receive $14.00 per share, along with a non-tradeable contingent value right that could yield up to an additional $2.75 per share, subject to specific milestones being met. The voting for shareholders regarding this merger is set for July 2, 2025, encouraging affected investors to seek guidance and evaluate their options carefully.
Another significant merger involves iCAD, Inc. (NASDAQ: ICAD), which is looking to merge with RadNet, Inc. Here, iCAD stockholders will receive 0.0677 shares of RadNet common stock for each share they hold at the merger's closing. This vote is scheduled for July 14, 2025, to finalize shareholder decisions regarding their investments. With potential implications on the stock valuations, the scrutiny over these terms by Monteverde & Associates aims to provide clarity and legal assistance to investors.
Lastly, Monteverde & Associates is focused on BioSig Technologies, Inc. (NASDAQ: BSGM) as it proposes a merger with Streamex Exchange Corporation. This merger entails the acquisition of all outstanding shares of Streamex according to a Share Purchase Agreement. This chained relationship marks a pivotal step for the company, which is also currently being evaluated by the firm to ensure shareholder interests are safeguarded throughout the process.
Monteverde & Associates insists that not all law firms are equal in their approaches. As a respected national class action securities firm with a successful track record in courts, including the U.S. Supreme Court, they advocate that shareholders should be proactive in seeking legal advice. They encourage any stakeholders in these companies to inquire regarding the firm’s past recoveries and strategies, ensuring that their legal representation meets the highest standards.
For any shareholder or investor concerned about these mergers, Monteverde & Associates offers resources and assistance without any cost or obligation. Interested individuals can easily access more information through their dedicated website or via direct contact with Juan Monteverde, urging a careful review of their shareholder rights in these evolving corporate landscapes. Furthermore, with upcoming votes set to take place across these companies in mid-2025, it is crucial for shareholders to remain informed of their options and the potential implications these mergers may carry for their investments.
Starting with Southern States Bancshares, Inc. (NASDAQ: SSBK), the firm has raised concerns regarding the terms of their proposed merger with FB Financial Corporation. According to the agreement, shareholders of Southern States will receive 0.800 shares of FB Financial's common stock for every share they hold. Investors are advised to act quickly, as a shareholder vote is scheduled for June 26, 2025. Monteverde & Associates emphasizes that potential impacts on shareholder value are critically assessed to protect the interests of investors.
In a similar vein, LENSAR, Inc. (NASDAQ: LNSR) is also under review for its merger with Alcon. Under the proposed terms, LENSAR shareholders will receive $14.00 per share, along with a non-tradeable contingent value right that could yield up to an additional $2.75 per share, subject to specific milestones being met. The voting for shareholders regarding this merger is set for July 2, 2025, encouraging affected investors to seek guidance and evaluate their options carefully.
Another significant merger involves iCAD, Inc. (NASDAQ: ICAD), which is looking to merge with RadNet, Inc. Here, iCAD stockholders will receive 0.0677 shares of RadNet common stock for each share they hold at the merger's closing. This vote is scheduled for July 14, 2025, to finalize shareholder decisions regarding their investments. With potential implications on the stock valuations, the scrutiny over these terms by Monteverde & Associates aims to provide clarity and legal assistance to investors.
Lastly, Monteverde & Associates is focused on BioSig Technologies, Inc. (NASDAQ: BSGM) as it proposes a merger with Streamex Exchange Corporation. This merger entails the acquisition of all outstanding shares of Streamex according to a Share Purchase Agreement. This chained relationship marks a pivotal step for the company, which is also currently being evaluated by the firm to ensure shareholder interests are safeguarded throughout the process.
Monteverde & Associates insists that not all law firms are equal in their approaches. As a respected national class action securities firm with a successful track record in courts, including the U.S. Supreme Court, they advocate that shareholders should be proactive in seeking legal advice. They encourage any stakeholders in these companies to inquire regarding the firm’s past recoveries and strategies, ensuring that their legal representation meets the highest standards.
For any shareholder or investor concerned about these mergers, Monteverde & Associates offers resources and assistance without any cost or obligation. Interested individuals can easily access more information through their dedicated website or via direct contact with Juan Monteverde, urging a careful review of their shareholder rights in these evolving corporate landscapes. Furthermore, with upcoming votes set to take place across these companies in mid-2025, it is crucial for shareholders to remain informed of their options and the potential implications these mergers may carry for their investments.
Topics Financial Services & Investing）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.